Astellas Astellas Pharma US Inc. / George Barrett Corp. / Item Development AB / Teva Teva Pharmaceutical Industries Ltd. / Astellas Pharma Inc. / King Pharmaceuticals Inc. / Teva Pharmaceutical Industries Ltd. / Astellas Pharma US Inc. / Astellas US LLC / Maribeth Landwehr Corporate Communications Astellas US LLC / Teva North America / James Green Corporate Affairs King Pharmaceuticals Inc. / /
Continent
North America / Europe / /
Country
Japan / United States / Israel / / /
Event
Business Partnership / Legal Issues / /
Facility
US District Court / /
IndustryTerm
supply chain / animal health pharmaceutical products / pharmaceutical industry / active pharmaceutical ingredients / pharmaceutical / generic and innovative human pharmaceuticals / generic pharmaceutical / manufacturing / pharmaceutical products / prescription pharmaceutical products / generic products / life-cycle management / /
MarketIndex
S&P 500 / /
Organization
US District Court / U.S. Securities and Exchange Commission / European Medicines Agency / U.S. Food and Drug Administration / /
Person
Masafumi Nogimori / Dan Suesskind / / /
Position
Chief Financial Officer / Exec. / Chief Executive Officer / global category leader / King / President and CEO / V.P. / Private / /
Contacts: Maribeth Landwehr Corporate Communications Astellas US LLC[removed]